# CLCNKB

## Overview
The CLCNKB gene encodes the chloride voltage-gated channel Kb (ClC-Kb), a transmembrane protein that is part of the CLC family of chloride channels. This protein plays a critical role in the renal system, particularly in the reabsorption of chloride ions in the kidneys, which is essential for maintaining electrolyte balance and proper kidney function (Krämer2008Mechanisms; Cheng2017Functional). ClC-Kb is primarily expressed in the basolateral membrane of the thick ascending limb of the loop of Henle and the distal convoluted tubule, where it facilitates the reabsorption of sodium chloride (NaCl) (TAJIMA2006Molecular; Zelikovic2003A). The protein functions as a homodimer and requires the accessory subunit barttin for proper membrane localization and activity (Poroca2017ClC; Jentsch2018CLC). Mutations in the CLCNKB gene can lead to Bartter syndrome type III, a disorder characterized by impaired renal salt reabsorption and electrolyte imbalances (Zhou2023A; Wang2020Splicing).

## Structure
The CLCNKB gene encodes the ClC-Kb chloride channel, a member of the CLC family of chloride channels. The ClC-Kb protein functions as a homodimer, with each protomer consisting of 687 amino acids. The primary structure includes a transmembrane domain with 17 α-helices and two intracellular cystathionine beta-synthase (CBS) domains (Louet2017In; Jentsch2018CLC). The secondary structure is characterized by these α-helices, which are variable in length and tilted, forming an internal anti-parallel repeat architecture (Poroca2017ClC).

The tertiary structure of ClC-Kb includes a transmembrane domain and a cytosolic domain containing CBS domains, which are typical of eukaryotic CLC proteins (Park2016Structure). The quaternary structure is a homodimer, with each subunit contributing to the formation of the ion selectivity filter for chloride conductance (Poroca2017ClC). The protein is N-glycosylated in the extracellular loop between helices L and M (Jentsch2018CLC).

ClC-Kb channels require the β-subunit barttin for proper function, stability, and trafficking to the plasma membrane (Poroca2017ClC). The absence of a 'gating glutamate' in ClC-Kb is a unique feature, replaced by valine or leucine, which influences the channel's gating properties (Jentsch2018CLC).

## Function
The CLCNKB gene encodes the ClC-Kb chloride channel, a voltage-gated channel crucial for chloride ion transport in the kidneys. This channel is primarily expressed in the basolateral membrane of the thick ascending limb of the loop of Henle and the distal convoluted tubule (DCT) (TAJIMA2006Molecular; Zelikovic2003A). ClC-Kb plays a vital role in transepithelial chloride transport, which is essential for maintaining electrolyte balance and proper kidney function (Krämer2008Mechanisms; Cheng2017Functional).

In healthy human cells, ClC-Kb facilitates the reabsorption of sodium chloride (NaCl) by allowing chloride ions to exit tubular epithelial cells into the interstitium, a process that is crucial for the kidney's ability to concentrate urine and maintain the corticomedullary osmotic gradient (Zelikovic2003A; Krämer2008Mechanisms). This function is essential for regulating blood pressure and plasma renin activity (Krämer2008Mechanisms).

The activity of ClC-Kb is modulated by the essential β-subunit barttin, encoded by the BSND gene, which is necessary for proper membrane insertion and function of the channel (Krämer2008Mechanisms; Cheng2017Functional). Proper function of ClC-Kb is critical for preventing conditions such as Bartter's syndrome, characterized by defective salt reabsorption and electrolyte imbalances (Cheng2017Functional).

## Clinical Significance
Mutations in the CLCNKB gene are primarily associated with Bartter syndrome type III, an autosomal recessive disorder characterized by metabolic alkalosis, renal salt wasting, hyperreninemia, and hyperaldosteronism, all occurring with normal blood pressure (Zhou2023A; Wang2020Splicing). This condition typically manifests in early childhood and includes symptoms such as hypokalemia, polyuria, polydipsia, and failure to thrive (Zhou2023A). The clinical presentation of Bartter syndrome type III can overlap with antenatal Bartter syndrome or Gitelman syndrome, particularly in terms of hypokalemic metabolic alkalosis and secondary aldosteronism (Zhou2023A).

The CLCNKB gene encodes the ClC-Kb chloride channel, which is crucial for chloride reabsorption in the kidney. Mutations in this gene lead to impaired channel function, reducing chloride and sodium reabsorption in the renal tubules and resulting in salt loss in urine (Wang2020Splicing). Various mutations, including missense, nonsense, splice site mutations, deletions, and insertions, have been identified in the CLCNKB gene, contributing to the phenotypic variability observed in patients (Cheng2017Functional; Han2019Thirteen). The severity of these mutations correlates with the phenotypic severity of Bartter syndrome, affecting factors such as age at diagnosis and plasma chloride concentration (Cheng2017Functional).

## Interactions
The CLCNKB gene encodes the ClC-Kb chloride channel, which interacts with the accessory subunit barttin, encoded by the BSND gene. Barttin is essential for the functional expression and proper localization of ClC-Kb channels at the plasma membrane. It enhances the surface expression of ClC-Kb by preventing its retention in the endoplasmic reticulum or Golgi apparatus, thereby facilitating its transport to the plasma membrane (Jentsch2018CLC; Sahbani2020Functional). Barttin binds directly to ClC-Kb, potentially through specific helices, and this interaction is crucial for the channel's activity and stability (Jentsch2018CLC).

Mutations in CLCNKB can disrupt these interactions, leading to reduced chloride currents and impaired channel function, as seen in conditions like Bartter's syndrome. For instance, the G167V and A242E mutations in ClC-Kb result in decreased membrane expression and reduced chloride currents, which can be partially rescued by increasing the ClC-Kb/barttin ratio (Sahbani2020Functional). The interaction with barttin is also implicated in the channel's response to external factors such as pH and calcium levels, which can be altered by specific mutations (Jentsch2018CLC).


## References


[1. (TAJIMA2006Molecular) Toshihiro TAJIMA, Mitsuru NAWATE, Yutaka TAKAHASHI, Yumiko MIZOGUCHI, Shigetaka SUGIHARA, Masaaki YOSHIMOTO, Mutsumi MURAKAMI, Masanori ADACHI, Katsuhiko TACHIBANA, Hiroshi MOCHIZUKI, and Kenji FUJIEDA. Molecular analysis of the clcnkb gene in japanese patients with classic bartter syndrome. Endocrine Journal, 53(5):647–652, 2006. URL: http://dx.doi.org/10.1507/ENDOCRJ.K06-034, doi:10.1507/endocrj.k06-034. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1507/ENDOCRJ.K06-034)

[2. (Wang2020Splicing) Chunli Wang, Yuan Han, Jiaran Zhou, Bixia Zheng, Wei Zhou, Huaying Bao, Zhanjun Jia, Aihua Zhang, Songming Huang, Guixia Ding, and Fei Zhao. Splicing characterization of clcnkb variants in four patients with type iii bartter syndrome. Frontiers in Genetics, February 2020. URL: http://dx.doi.org/10.3389/fgene.2020.00081, doi:10.3389/fgene.2020.00081. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2020.00081)

[3. (Cheng2017Functional) Chih‐Jen Cheng, Yi‐Fen Lo, Jen‐Chi Chen, Chou‐Long Huang, and Shih‐Hua Lin. Functional severity of clcnkb mutations correlates with phenotypes in patients with classic bartter’s syndrome. The Journal of Physiology, 595(16):5573–5586, June 2017. URL: http://dx.doi.org/10.1113/jp274344, doi:10.1113/jp274344. This article has 26 citations.](https://doi.org/10.1113/jp274344)

[4. (Han2019Thirteen) Yue Han, Hai Cheng, Shihong Shao, Yanhua Lang, Xiangzhong Zhao, Yi Lin, Sai Wang, Xiaomeng Shi, Zhiying Liu, and Leping Shao. Thirteen novel clcnkb variants and genotype/phenotype association study in 42 chinese patients with bartter syndrome type 3. Endocrine, 68(1):192–202, December 2019. URL: http://dx.doi.org/10.1007/s12020-019-02156-9, doi:10.1007/s12020-019-02156-9. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12020-019-02156-9)

[5. (Zhou2023A) Lan Zhou, Xiaohui Chen, Jiaojiao Xiong, and Ling Lei. A mosaic mutation in the clcnkb gene causing bartter syndrome: a case report. Frontiers in Pediatrics, April 2023. URL: http://dx.doi.org/10.3389/fped.2023.1034923, doi:10.3389/fped.2023.1034923. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fped.2023.1034923)

[6. (Krämer2008Mechanisms) Bernhard K Krämer, Tobias Bergler, Benjamin Stoelcker, and Siegfried Waldegger. Mechanisms of disease: the kidney-specific chloride channels clcka and clckb, the barttin subunit, and their clinical relevance. Nature Clinical Practice Nephrology, 4(1):38–46, January 2008. URL: http://dx.doi.org/10.1038/ncpneph0689, doi:10.1038/ncpneph0689. This article has 72 citations.](https://doi.org/10.1038/ncpneph0689)

[7. (Jentsch2018CLC) Thomas J. Jentsch and Michael Pusch. Clc chloride channels and transporters: structure, function, physiology, and disease. Physiological Reviews, 98(3):1493–1590, July 2018. URL: http://dx.doi.org/10.1152/physrev.00047.2017, doi:10.1152/physrev.00047.2017. This article has 308 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00047.2017)

[8. (Louet2017In) Maxime Louet, Sara Bitam, Naziha Bakouh, Yohan Bignon, Gabrielle Planelles, David Lagorce, Maria A. Miteva, Dominique Eladari, Jacques Teulon, and Bruno O. Villoutreix. In silico model of the human clc-kb chloride channel: pore mapping, biostructural pathology and drug screening. Scientific Reports, August 2017. URL: http://dx.doi.org/10.1038/s41598-017-07794-5, doi:10.1038/s41598-017-07794-5. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-07794-5)

[9. (Poroca2017ClC) Diogo R. Poroca, Ryan M. Pelis, and Valérie M. Chappe. Clc channels and transporters: structure, physiological functions, and implications in human chloride channelopathies. Frontiers in Pharmacology, March 2017. URL: http://dx.doi.org/10.3389/fphar.2017.00151, doi:10.3389/fphar.2017.00151. This article has 87 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2017.00151)

[10. (Zelikovic2003A) Israel Zelikovic, Raymonde Szargel, Ali Hawash, Valentina Labay, Ihab Hatib, Nadine Cohen, and Farid Nakhoul. A novel mutation in the chloride channel gene, clcnkb, as a cause of gitelman and bartter syndromes. Kidney International, 63(1):24–32, January 2003. URL: http://dx.doi.org/10.1046/j.1523-1755.2003.00730.x, doi:10.1046/j.1523-1755.2003.00730.x. This article has 145 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1046/j.1523-1755.2003.00730.x)

[11. (Sahbani2020Functional) Dalila Sahbani, Bice Strumbo, Silvana Tedeschi, Elena Conte, Giulia Maria Camerino, Elisa Benetti, Giovanni Montini, Gabriella Aceto, Giuseppe Procino, Paola Imbrici, and Antonella Liantonio. Functional study of novel bartter’s syndrome mutations in clc-kb and rescue by the accessory subunit barttin toward personalized medicine. Frontiers in Pharmacology, March 2020. URL: http://dx.doi.org/10.3389/fphar.2020.00327, doi:10.3389/fphar.2020.00327. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2020.00327)

[12. (Park2016Structure) Eunyong Park, Ernest B. Campbell, and Roderick MacKinnon. Structure of a clc chloride ion channel by cryo-electron microscopy. Nature, 541(7638):500–505, December 2016. URL: http://dx.doi.org/10.1038/nature20812, doi:10.1038/nature20812. This article has 131 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature20812)